(S)-2-(1-BOC-2-pyrrolidinyl)acetic acid → (S)-tert-butyl 2-((5-phenyl-1,3,4-oxadiazol-2-yl)methyl)pyrrolidine-1-carboxylate
Reaktionsgleichung
[C:1]([O:5][C:6]([N:8]1[CH2:12][CH2:11][CH2:10][C@H:9]1[CH2:13][C:14]([OH:16])=O)=[O:7])([CH3:4])([CH3:3])[CH3:2].[C:17]1([C:23]2NN=[N:25][N:24]=2)[CH:22]=[CH:21][CH:20]=[CH:19][CH:18]=1>>[C:1]([O:5][C:6]([N:8]1[CH2:12][CH2:11][CH2:10][C@H:9]1[CH2:13][C:14]1[O:16][C:23]([C:17]2[CH:22]=[CH:21][CH:20]=[CH:19][CH:18]=2)=[N:24][N:25]=1)=[O:7])([CH3:2])([CH3:3])[CH3:4]Komponenten
3
Versuchsvorschrift
The title compound was prepared from (S)-2-carboxymethyl-pyrrolidine-1-carboxylic acid tert butyl ester (2.50) and 5-phenyltetrazole (1.59 g) according to the method of description 1.
Quellen und Nachweise
- ORD-Eintrag
- ord-3e7d6eea330a4bcb9791084f1cebf4c9
- Quelldatensatz
- uspto-grants-2011_05